BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc. (BEAM) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 49% planned / 51% discretionary
Largest single sale: $8.9M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Simon Amy | Chief Medical Officer | Sell 10b5-1 | 16,667 | $25.74 | $429.0K | 85,696 −16.3% of holding | |
| Evans John M. 2 fills | CEO | Sell 10b5-1 | 25,000 | $34.31 | $857.7K | 1,049,105 −2.3% of holding | |
| Simon Amy | Chief Medical Officer | Sell 10b5-1 | 373 | $34.73 | $13.0K | 102,363 −0.4% of holding | |
| Evans John M. 2 fills | CEO | Sell 10b5-1 | 25,000 | $35.49 | $887.4K | 1,058,784 −2.3% of holding | |
| FMR LLC | 10% Owner | Sell | 251,488 | $35.26 | $8.9M | 854,583 −22.7% of holding | |
| FMR LLC | 10% Owner | Sell | 33,372 | $35.12 | $1.2M | 1,106,071 −2.9% of holding | |
| Evans John M. | CEO | Sell 10b5-1 | 30,078 | $24.58 | $739.3K | 1,047,205 −2.8% of holding | |
| Ciaramella Giuseppe | President | Sell 10b5-1 | 11,810 | $24.58 | $290.3K | 218,406 −5.1% of holding | |
| Simon Amy | Chief Medical Officer | Sell 10b5-1 | 6,700 | $24.58 | $164.7K | 102,735 −6.1% of holding | |
| Bellon Christine | Chief Legal Officer | Sell 10b5-1 | 5,956 | $24.58 | $146.4K | 109,711 −5.1% of holding | |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sell 10b5-1 | 3,242 | $24.58 | $79.7K | 51,171 −6% of holding | |
| Evans John M. | CEO | Sell 10b5-1 | 25,000 | $22.76 | $569.1K | 986,667 −2.5% of holding | |
| Evans John M. | CEO | Sell 10b5-1 | 25,000 | $22.37 | $559.2K | 986,667 −2.5% of holding | |
| Ciaramella Giuseppe | President | Sell 10b5-1 | 35,000 | $32.00 | $1.1M | 190,216 −15.5% of holding | |
| Evans John M. 2 fills | CEO | Sell 10b5-1 | 25,000 | $28.36 | $708.9K | 989,573 −2.5% of holding | |
| Evans John M. 2 fills | CEO | Sell 10b5-1 | 25,000 | $29.38 | $734.6K | 995,334 −2.5% of holding | |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sell 10b5-1 | 6,198 | $35.00 | $216.9K | 34,813 −15.1% of holding | |
| Bellon Christine | Chief Legal Officer | Sell 10b5-1 | 1,371 | $34.00 | $46.6K | 95,667 −1.4% of holding | |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sell 10b5-1 | 3,034 | $30.12 | $91.4K | 41,011 −6.9% of holding | |
| Bellon Christine 3 fills | Chief Legal Officer | Sell 10b5-1 | 18,629 | $34.61 | $644.8K | 113,556 −14.1% of holding | |
| Emany Sravan Kumar | Chief Financial Officer | Sell 10b5-1 | 6,294 | $27.10 | $170.6K | 73,706 −7.9% of holding | |
| Bellon Christine | Chief Legal Officer | Sell 10b5-1 | 1,254 | $27.10 | $34.0K | 115,667 −1.1% of holding | |
| FMR LLC | 10% Owner | Sell | 459 | $26.68 | $12.2K | 14 −97% of holding | |
| Evans John M. | CEO | Sell 10b5-1 | 25,000 | $24.63 | $615.7K | 986,667 −2.5% of holding | |
| Evans John M. | CEO | Sell 10b5-1 | 25,000 | $24.51 | $612.7K | 986,667 −2.5% of holding | |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sell 10b5-1 | 467 | $24.53 | $11.5K | 44,045 −1% of holding | |
| Bellon Christine | Chief Legal Officer | Sell 10b5-1 | 373 | $24.53 | $9.1K | 116,921 −0.3% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.